SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950133-02-001444
Filing Date
2002-04-10
Accepted
2002-04-10 00:00:00
Documents
2
Period of Report
2002-05-08

Document Format Files

Seq Description Document Type Size
1 NOTICE AND PROXY STATEMENT FOR NOVAVAX, INC. w58175def14a.htm DEF 14A 222603
3 GRAPHIC w58175w5817501.gif GRAPHIC 13823
  Complete submission text file 0000950133-02-001444.txt   238073
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-26770 | Film No.: 02606693
SIC: 2836 Biological Products, (No Diagnostic Substances)